Verona Pharma Plc Stock Revenue
| VRNA Stock | USD 61.39 3.97 6.07% |
Verona Pharma PLC fundamentals help investors to digest information that contributes to Verona Pharma's financial success or failures. It also enables traders to predict the movement of Verona Stock. The fundamental analysis module provides a way to measure Verona Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Verona Pharma stock.
Verona |
Verona Pharma PLC Company Revenue Analysis
Verona Pharma's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Verona Pharma Revenue | 42.28 M |
Most of Verona Pharma's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verona Pharma PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Verona Pharma PLC reported 42.28 M of revenue. This is 99.45% lower than that of the Pharmaceuticals sector and 94.31% lower than that of the Health Care industry. The revenue for all United States stocks is 99.55% higher than that of the company.
Verona Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Verona Pharma's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Verona Pharma could also be used in its relative valuation, which is a method of valuing Verona Pharma by comparing valuation metrics of similar companies.Verona Pharma is currently under evaluation in revenue category among its peers.
Verona Fundamentals
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.24 | ||||
| Operating Margin | (0.49) % | ||||
| Current Valuation | 5.28 B | ||||
| Shares Outstanding | 84.98 M | ||||
| Shares Owned By Insiders | 6.04 % | ||||
| Shares Owned By Institutions | 85.24 % | ||||
| Number Of Shares Shorted | 7.78 M | ||||
| Price To Earning | (9.15) X | ||||
| Price To Book | 27.15 X | ||||
| Price To Sales | 205.71 X | ||||
| Revenue | 42.28 M | ||||
| Gross Profit | 39.7 M | ||||
| EBITDA | (138.53 M) | ||||
| Net Income | (173.42 M) | ||||
| Cash And Equivalents | 111.51 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 2.36 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.57 X | ||||
| Book Value Per Share | 2.42 X | ||||
| Cash Flow From Operations | (122.2 M) | ||||
| Short Ratio | 5.86 X | ||||
| Earnings Per Share | (2.16) X | ||||
| Target Price | 81.0 | ||||
| Number Of Employees | 209 | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 8.7 B | ||||
| Total Asset | 474.24 M | ||||
| Retained Earnings | (562.4 M) | ||||
| Working Capital | 410.89 M | ||||
| Net Asset | 474.24 M |
About Verona Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verona Pharma PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verona Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verona Pharma PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Verona Pharma PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verona Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verona Pharma Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verona Pharma Plc Stock:Check out Verona Pharma Piotroski F Score and Verona Pharma Altman Z Score analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verona Pharma. If investors know Verona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verona Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Verona Pharma PLC is measured differently than its book value, which is the value of Verona that is recorded on the company's balance sheet. Investors also form their own opinion of Verona Pharma's value that differs from its market value or its book value, called intrinsic value, which is Verona Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verona Pharma's market value can be influenced by many factors that don't directly affect Verona Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verona Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verona Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verona Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.